Optogenerapy aims to develop and demonstrate a new optogenetics implant for controlled beta interferon (IFN- ß) protein delivery for treating patients suffering from multiple sclerosis
Are you a clinician?
We are looking for clinicians working on Multiple Sclerosis willing to participate in the project by providing their feedback on Optogenerapy’s medical device by answering a short survey via email or telephone call. Your feedback will be considered by project partners and integrated, when possible, during the project development.
Interested clinicians will be also invited to Optogenerapy’s clinical training workshops, aiming at presenting the implant to the medical professional community and enriching the clinical know-how.
Improve drug effectiveness Improve compliance with drug taking
Reduce direct and indirect costs
linked to Multiple Sclerosis
Social awareness of efficient therapies
improving patient compliance